Suppr超能文献

造血干细胞移植后青年幸存者的健康相关生活质量。

Health-Related Quality of Life in Young Adult Survivors of Hematopoietic Cell Transplantation.

机构信息

Department of Pediatric Hematology, Oncology, and Blood and Marrow Transplantation, Pediatric Institute, Cleveland Clinic Foundation, Cleveland, Ohio; Department of Hematology and Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, Ohio.

Fred Hutchinson Cancer Center, University of Washington School of Medicine, Seattle, Washington.

出版信息

Transplant Cell Ther. 2022 Oct;28(10):701.e1-701.e7. doi: 10.1016/j.jtct.2022.07.018. Epub 2022 Jul 22.

Abstract

Young adults (YA), age 18 to 39 years, are at a stage of life that may make them more vulnerable than older adults to impairments in health-related quality of life (HRQOL) during and after hematopoietic cell transplantation (HCT). Health self-efficacy (HSE), the belief that one can implement strategies to produce a desired health outcome, has been associated with health outcomes in oncology research. Little is known about HRQOL or HSE in YA HCT survivors compared with older HCT survivors. Given the age-specific psychosocial challenges facing YA HCT recipients and research on non-transplant YA cancer survivors, we hypothesized that YA survivors would have worse post-HCT HRQOL compared with older adults, and that among YA HCT survivors, higher levels of HSE would be associated with higher levels of HRQOL and lower levels of cancer-related distress. This was a cross-sectional secondary analysis of 2 combined baseline datasets from multicenter studies of HCT survivors approached for participation in clinical trials of survivorship interventions. Participants from 20 transplantation centers in the United States were at 1 to 10 years post-HCT and age ≥18 years at the time of study enrollment, had no evidence of disease relapse/progression or subsequent malignancies, and could read English adequately to consent for and complete assessments. Medical record and patient-reported data were obtained for demographics and HCT-related clinical factors and complications (eg, total body irradiation, chronic graft-versus-host disease [cGVHD]). Participants completed surveys on HRQOL, including the Short-Form [SF]-12, HSE, and Cancer and Treatment Distress (CTXD), which includes 6 subscales and reports an overall mean score. On the SF-12, both the Mental Component Score (MCS) and Physical Component Score (PCS) were calculated. Two cohorts were compared: YAs (age 18 to 39 years at transplantation) and older adults (age ≥40 years at transplantation). Multiple linear regression analyses identified factors associated with HSE, PCS, MCS, and CTXD in YAs. In this analysis of 979 survivors, compared with the older adults, the YA participants had lower median mental health scores (SF-12 MCS: 48.40 versus 50.23; P = .04) and higher cancer-related distress (CTXD: .96 versus .85; P = .04), but better physical health (SF-12 PCS: 48.99 versus 47.18; P = .049). Greater overall cancer-related distress was driven by higher levels of uncertainty, financial concern, and medical demand subscales for YAs compared with older adults. Young adults also had lower HSE (2.93 versus 3.08; P = .0004). In a multivariate model, HSE was strongly associated with age group (P = .0005) after adjusting for multiple other transplantation-related factors. Among YAs, HSE was associated with the SF-12 MCS and PCS and the CTXD, and HSE remained significant after adjusting for other transplantation-related factors. Overall, the YA HCT survivors had lower mental health, increased cancer-related distress, and lower levels of HSE compared with the older adults. Although the direction of these effects cannot be determined with these data, the strong association between HSE and HRQOL among YAs suggests that targeting interventions to improve HSE may have broad impact on health outcomes.

摘要

年轻人(YA),年龄在 18 至 39 岁之间,处于人生的一个阶段,在造血细胞移植(HCT)期间和之后,他们的健康相关生活质量(HRQOL)可能比老年人更容易受到损害。健康自我效能感(HSE)是指一个人相信自己能够实施策略来产生预期的健康结果的信念,它与肿瘤学研究中的健康结果有关。与老年 HCT 幸存者相比,YA HCT 幸存者的 HRQOL 或 HSE 知之甚少。鉴于 YA HCT 接受者面临的特定于年龄的心理社会挑战以及针对非移植 YA 癌症幸存者的研究,我们假设 YA 幸存者在 HCT 后 HRQOL 会比老年人差,并且在 YA HCT 幸存者中,更高的 HSE 水平与更高的 HRQOL 和更低的癌症相关困扰有关。这是对 2 项联合基线数据集的横断面二次分析,这些数据集来自美国 20 个移植中心的多中心 HCT 幸存者研究,这些幸存者参与了生存干预的临床试验。研究纳入的参与者在研究入组时 HCT 后 1 至 10 年,年龄≥18 岁,无疾病复发/进展或随后的恶性肿瘤证据,并且能够足够阅读英语以同意并完成评估。从美国 20 个移植中心获得了与人口统计学和 HCT 相关的临床因素和并发症(例如全身照射、慢性移植物抗宿主病[cGVHD])的病历和患者报告数据。参与者完成了 HRQOL 调查,包括短表[SF]-12、HSE 和癌症和治疗困扰(CTXD),其中包括 6 个亚量表,并报告了一个总体平均得分。在 SF-12 中,计算了心理成分评分(MCS)和身体成分评分(PCS)。比较了两个队列:年轻人(移植时年龄为 18 至 39 岁)和老年人(移植时年龄≥40 岁)。多元线性回归分析确定了与 YA 的 HSE、PCS、MCS 和 CTXD 相关的因素。在这项对 979 名幸存者的分析中,与老年人相比,YA 参与者的心理健康评分中位数较低(SF-12 MCS:48.40 与 50.23;P=0.04),癌症相关困扰较高(CTXD:0.96 与 0.85;P=0.04),但身体健康较好(SF-12 PCS:48.99 与 47.18;P=0.049)。对于年轻人来说,整体癌症相关困扰较高是由于不确定性、财务担忧和医疗需求亚量表水平较高所致。年轻人的 HSE 也较低(2.93 与 3.08;P=0.0004)。在多变量模型中,在调整了多个其他移植相关因素后,HSE 与年龄组(P=0.0005)密切相关。在 YA 中,HSE 与 SF-12 MCS 和 PCS 以及 CTXD 相关,并且在调整了其他移植相关因素后,HSE 仍然具有统计学意义。总体而言,与老年人相比,YA HCT 幸存者的心理健康状况较差,癌症相关困扰增加,HSE 水平较低。尽管这些数据不能确定这些影响的方向,但 HSE 与 YA 中的 HRQOL 之间的强烈关联表明,针对提高 HSE 的干预措施可能对健康结果产生广泛影响。

相似文献

1
Health-Related Quality of Life in Young Adult Survivors of Hematopoietic Cell Transplantation.
Transplant Cell Ther. 2022 Oct;28(10):701.e1-701.e7. doi: 10.1016/j.jtct.2022.07.018. Epub 2022 Jul 22.
2
Self-Efficacy for Symptom Management in Long-Term Adult Hematopoietic Stem Cell Survivors.
Transplant Cell Ther. 2022 Sep;28(9):606.e1-606.e8. doi: 10.1016/j.jtct.2022.05.035. Epub 2022 May 31.
3
Health-Related Quality of Life Outcomes in Older Hematopoietic Cell Transplantation Survivors.
Transplant Cell Ther. 2023 Mar;29(3):202.e1-202.e8. doi: 10.1016/j.jtct.2022.11.016. Epub 2022 Nov 23.
4
5
Cancer and treatment distress psychometric evaluation over time: A BMT CTN 0902 secondary analysis.
Cancer. 2017 Apr 15;123(8):1416-1423. doi: 10.1002/cncr.30454. Epub 2016 Nov 28.
6
Return to Work Among Young Adult Survivors of Allogeneic Hematopoietic Cell Transplantation in the United States.
Transplant Cell Ther. 2021 Aug;27(8):679.e1-679.e8. doi: 10.1016/j.jtct.2021.04.013. Epub 2021 Apr 22.
7
Patient-Reported Outcomes in Long-Term Survivors of Autologous Hematopoietic Cell Transplantation in Multiple Myeloma.
Transplant Cell Ther. 2023 Jun;29(6):388.e1-388.e6. doi: 10.1016/j.jtct.2023.02.011. Epub 2023 Mar 2.

本文引用的文献

1
Cancer survivorship care for young adults: a risk-stratified, multicenter randomized controlled trial to improve symptoms.
J Cancer Surviv. 2022 Oct;16(5):1149-1164. doi: 10.1007/s11764-021-01105-8. Epub 2021 Sep 29.
2
Persistent Symptoms, Quality of Life, and Correlates with Health Self-Efficacy in Adolescent and Young Adult Survivors of Childhood Cancer.
J Adolesc Young Adult Oncol. 2022 Aug;11(4):410-418. doi: 10.1089/jayao.2021.0104. Epub 2021 Sep 28.
4
Who Enrolls in an Online Cancer Survivorship Program? Reach of the INSPIRE Randomized Controlled Trial for Hematopoietic Cell Transplantation Survivors.
Biol Blood Marrow Transplant. 2020 Oct;26(10):1948-1954. doi: 10.1016/j.bbmt.2020.06.017. Epub 2020 Jun 26.
5
Quality-of-Life Trajectories in Adolescent and Young Adult versus Older Adult Allogeneic Hematopoietic Cell Transplantation Recipients.
Biol Blood Marrow Transplant. 2020 Aug;26(8):1505-1510. doi: 10.1016/j.bbmt.2020.03.023. Epub 2020 May 19.
6
Age and gender differences in financial distress among hematopoietic cell transplant survivors.
Support Care Cancer. 2020 Sep;28(9):4361-4371. doi: 10.1007/s00520-019-05291-1. Epub 2020 Jan 8.
9
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验